N-[(3-methoxy-2-phenylmethoxyphenyl)methyl]-1-(4-methylcyclohexyl)methanamine;N,N,2-trimethylquinazolin-4-amine
C34H44N4O2 — CID 142229717
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(3-methoxy-2-phenylmethoxyphenyl)methyl]-1-(4-methylcyclohexyl)methanamine;N,N,2-trimethylquinazolin-4-amine
N-[(3-methoxy-2-phenylmethoxyphenyl)methyl]-1-(4-methylcyclohexyl)methanamine;N,N,2-trimethylquinazolin-4-amine (PubChem CID 142229717) has the molecular formula C34H44N4O2 and a molecular weight of 540.75 g/mol. Its IUPAC name is N-[(3-methoxy-2-phenylmethoxyphenyl)methyl]-1-(4-methylcyclohexyl)methanamine;N,N,2-trimethylquinazolin-4-amine.
Molecular Properties
| Compound Name | N-[(3-methoxy-2-phenylmethoxyphenyl)methyl]-1-(4-methylcyclohexyl)methanamine;N,N,2-trimethylquinazolin-4-amine |
|---|---|
| PubChem CID | 142229717 |
| Molecular Formula | C34H44N4O2 |
| Molecular Weight | 540.75 g/mol |
| Exact Mass | 540.35 |
| IUPAC Name | N-[(3-methoxy-2-phenylmethoxyphenyl)methyl]-1-(4-methylcyclohexyl)methanamine;N,N,2-trimethylquinazolin-4-amine |
| SMILES | COc1cccc(CNCC2CCC(C)CC2)c1OCc1ccccc1.Cc1nc(N(C)C)c2ccccc2n1 |
| InChI | InChI=1S/C23H31NO2.C11H13N3/c1-18-11-13-19(14-12-18)15-24-16-21-9-6-10-22(25-2)23(21)26-17-20-7-4-3-5-8-20;1-8-12-10-7-5-4-6-9(10)11(13-8)14(2)3/h3-10,18-19,24H,11-17H2,1-2H3;4-7H,1-3H3 |
| InChIKey | HROKIMNWEKHANG-UHFFFAOYSA-N |
| XLogP | 7.19 |
| TPSA | 59.51 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 540.75 |
| LogP ≤ 5 | 7.19 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142229717 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.